PRESS RELEASE published on 07/29/2025 at 14:00, 10 months 19 days ago Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101 Eckert & Ziegler chosen as US manufacturer for Archeus' ART-101 radiopharmaceutical, targeting prostate cancer. Collaboration to support Phase 1 trial with state-of-the-art facility in Boston, MA Eckert & Ziegler Prostate Cancer Radiopharmaceutical ART-101 Archeus
BRIEF published on 07/28/2025 at 14:35, 10 months 20 days ago Eckert & Ziegler Completes Capital Increase, Prepares Share Split Liquidity Eckert & Ziegler Capital Increase Share Split Nuclear Medicine
PRESS RELEASE published on 07/28/2025 at 14:30, 10 months 20 days ago Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation. Eckert & Ziegler SE increases capital and prepares for share split, aiming to enhance share liquidity and trading. Leading in isotope-related components for nuclear medicine and radiation therapy Liquidity Eckert & Ziegler Capital Increase Share Split Isotope-related Components
BRIEF published on 07/15/2025 at 14:05, 11 months 2 days ago Eckert & Ziegler's Training Program Recognized for Excellence Training Excellence Berlin Chamber Award Trainee Retention Career Prospects Future Applications
PRESS RELEASE published on 07/15/2025 at 14:00, 11 months 2 days ago Eckert & Ziegler: Outstanding Training Quality Once Again Awarded Eckert & Ziegler SE awarded for exceptional training quality by Berlin Chamber of Industry and Commerce for the fourth consecutive time, emphasizing practical experience and career prospects for trainees Eckert & Ziegler Career Prospects Training Quality Berlin Chamber Of Industry And Commerce Trainee Team
BRIEF published on 06/18/2025 at 16:10, 11 months 29 days ago Eckert & Ziegler SE Declares EUR 0.50 Dividend at Annual General Meeting Annual General Meeting Shareholders Dividend Financial Year 2024 Eckert & Ziegler SE
PRESS RELEASE published on 06/18/2025 at 16:05, 11 months 29 days ago Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50 Eckert & Ziegler SE's Annual General Meeting approves dividend of EUR 0.50 per share for 2024 fiscal year. Detailed voting results available online Annual General Meeting Shareholders Voting Results Dividend Eckert & Ziegler SE
BRIEF published on 06/05/2025 at 10:05, 1 year ago Eckert & Ziegler Expands with Approval of Illuccix® in Germany Gallium-68 Nuclear Medicine Prostate Cancer Illuccix® PSMA-PET Imaging
PRESS RELEASE published on 06/05/2025 at 10:00, 1 year ago Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany Eckert & Ziegler announces the approval of Illuccix® PSMA-PET Imaging Agent in Germany, expanding its nuclear medicine portfolio and partnership with Telix Pharmaceuticals Eckert & Ziegler Germany Approval Illuccix PSMA-PET
BRIEF published on 05/30/2025 at 10:05, 1 year ago Eckert & Ziegler Hosts Successful Boston Radionuclide Theranostics Forum Precision Oncology Industry Collaboration Radiopharmaceuticals Theranostics Forum Event Insights
Published on 06/17/2026 at 16:55, 1 hour 40 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/17/2026 at 16:45, 1 hour 50 minutes ago Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean
Published on 06/17/2026 at 14:30, 4 hours 5 minutes ago Solitario Advances 2026 Ponderosa Drilling Program
Published on 06/17/2026 at 14:00, 4 hours 35 minutes ago CHAR Tech Reminds Shareholders of June 18 Investor Update Call
Published on 06/17/2026 at 18:23, 12 minutes ago EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG
Published on 06/17/2026 at 18:05, 30 minutes ago WACACO LAUNCHES PRESTINA, A PATENTED MANUAL COFFEE BREWER THAT TURNS THE CUP INTO THE PRESS
Published on 06/17/2026 at 17:48, 47 minutes ago FIGEAC AÉRO: FIGEAC AÉRO INCREASES ITS EXPOSURE TO THE RAFALE PROGRAMME WITH CANARDS
Published on 06/17/2026 at 17:05, 1 hour 30 minutes ago 6 Awards Mark Record-Breaking Performance for Cannabis Breeder 42 Fast Buds at Autoflower World Cup 2026
Published on 06/17/2026 at 08:45, 9 hours 50 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 6 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 19 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 1 day 23 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026